Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -21.90%43.35M | -3.64%68.43M | -26.48%43.45M | -2.39%71.63M | -24.23%55.51M | -13.78%71.02M | -61.41%59.1M | -52.00%73.38M | -53.62%73.25M | -50.62%82.36M |
Transactional financial assets | 1,281.51%17.13M | --8.3M | --4.8M | --9.8M | --1.24M | ---- | ---- | ---- | ---- | -53.30%17.01M |
Notes receivable and accounts receivable | 21.47%390.72M | 32.03%340.33M | 58.28%339.39M | 92.27%386.41M | 43.48%321.65M | 20.33%257.77M | -2.20%214.42M | -2.66%200.97M | 9.89%224.18M | 2.24%214.22M |
-Notes receivable | 1.55%47.46M | 6.07%37.73M | 49.18%44.09M | 143.02%79.19M | 39.44%46.74M | 11.77%35.57M | -18.51%29.56M | 15.45%32.58M | 25.05%33.52M | 28.17%31.83M |
-Accounts receivable | 24.86%343.25M | 36.19%302.6M | 59.74%295.3M | 82.45%307.22M | 44.19%274.91M | 21.82%222.2M | 1.04%184.86M | -5.53%168.38M | 7.60%190.66M | -1.24%182.39M |
Other receivables (including interest and dividends) | 24.39%19.55M | 11.60%29.42M | 26.12%29.79M | 40.34%29.01M | -24.56%15.71M | 1,255.90%26.36M | 1,181.34%23.62M | 796.26%20.67M | 794.96%20.83M | -64.75%1.94M |
-Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --684K | ---- |
-Other receivable | 24.39%19.55M | ---- | 26.12%29.79M | ---- | -22.00%15.71M | ---- | 1,181.34%23.62M | ---- | 765.57%20.14M | ---- |
Contractual assets | 31.26%15.37M | --20.48M | --20.54M | --13.71M | --11.71M | ---- | ---- | ---- | ---- | ---- |
Advance payment | 137.23%7.47M | -84.22%2.52M | -10.12%9.47M | -37.74%10.52M | -79.18%3.15M | 56.25%16M | 94.07%10.53M | 35.45%16.89M | 91.83%15.12M | 62.51%10.24M |
Inventories | 16.90%106.5M | 58.86%140.55M | 47.39%109.73M | -18.17%89.22M | 75.82%91.1M | 70.60%88.48M | 23.70%74.45M | 98.90%109.03M | 0.47%51.81M | -0.95%51.86M |
Receivable financing | 38.04%46.96M | 66.94%34.52M | 48.87%25.68M | 115.36%32.31M | 48.10%34.02M | 102.32%20.68M | -25.54%17.25M | -42.85%15.01M | 1.77%22.97M | -21.60%10.22M |
Other current assets | -20.14%7.21M | -16.64%6.32M | 0.60%8.86M | -49.03%5.3M | 674.20%9.03M | 407.46%7.58M | 370.03%8.8M | 207.09%10.4M | -65.49%1.17M | -47.42%1.49M |
Total current assets | 20.46%654.25M | 33.41%650.88M | 44.96%591.7M | 45.16%647.91M | 32.68%543.12M | 25.31%487.88M | -15.28%408.17M | -9.87%446.35M | -15.90%409.34M | -20.99%389.35M |
Non Current assets | ||||||||||
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | 0.00%22.03M | 0.00%22.03M | 0.00%22.03M | 0.00%22.03M | 274.67%22.03M |
Fixed assets | -9.73%257.95M | ---- | 4.35%264.47M | ---- | 59.86%285.75M | ---- | 381.61%253.44M | ---- | 235.65%178.75M | ---- |
Constru in process | 89.39%1.56M | ---- | -40.86%4.49M | ---- | -76.80%821.3K | ---- | -91.22%7.59M | ---- | -94.23%3.54M | ---- |
Intangible assets | -6.48%178.31M | 55.66%181.56M | 101.73%184.17M | 102.54%187.41M | 185.58%190.66M | 73.42%116.64M | 769.94%91.3M | 783.24%92.53M | 533.73%66.76M | 550.70%67.26M |
Goodwill | 0.00%104.02M | 189.73%104.02M | 609.51%104.02M | 892.01%104.02M | 892.01%104.02M | 242.39%35.9M | 85,651.10%14.66M | 61,231.17%10.49M | 61,231.17%10.49M | 61,231.17%10.49M |
Long deferred expense | -32.68%902.51K | 14.17%1.05M | 68.89%1.24M | 37.90%1.16M | 71.93%1.34M | 13.24%922.12K | -27.95%733.75K | -27.48%838.8K | -42.66%779.74K | -13.74%814.33K |
Deferred tax assets | -6.96%60.03M | -0.66%57.88M | 18.61%56.32M | 87.90%54.34M | 157.16%64.53M | 199.15%58.27M | 448.38%47.48M | 477.68%28.92M | 543.86%25.09M | 579.92%19.48M |
Usufruct assets | -47.83%4.85M | 54.94%5.82M | 121.07%7.45M | 136.08%8.02M | 172.17%9.3M | 171.12%3.75M | 335.71%3.37M | 230.14%3.4M | 160.42%3.42M | -34.12%1.38M |
Other non current assets | -59.38%1.06M | -93.18%755.87K | -18.78%1.64M | -94.66%831.13K | -77.00%2.6M | 159.07%11.09M | -89.22%2.02M | -5.09%15.56M | 277.00%11.31M | 36,048.78%4.28M |
Total non current assets | -7.60%617.08M | 20.71%625.52M | 35.64%632.08M | 40.41%639.11M | 93.53%667.87M | 64.48%518.19M | 132.22%466.01M | 158.91%455.18M | 120.19%345.11M | 146.52%315.05M |
Total assets | 4.98%1.27B | 26.87%1.28B | 39.99%1.22B | 42.76%1.29B | 60.51%1.21B | 42.83%1.01B | 28.09%874.18M | 34.35%901.53M | 17.25%754.44M | 13.50%704.4M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 26.08%251.24M | 35.21%249.4M | 62.94%229.22M | 121.34%230.38M | 215.62%199.26M | 221.13%184.46M | 186.28%140.67M | 177.81%104.09M | 384.91%63.13M | 186.84%57.44M |
Notes payable and accounts payable | 14.56%87.62M | 44.03%92.44M | 186.12%86.56M | 102.27%96.35M | 160.69%76.49M | 121.62%64.18M | -0.79%30.25M | 110.64%47.63M | 9.29%29.34M | -19.29%28.96M |
-Accounts payable | 14.56%87.62M | 44.03%92.44M | 186.12%86.56M | 102.27%96.35M | 160.69%76.49M | 121.62%64.18M | -0.79%30.25M | 110.64%47.63M | 9.29%29.34M | -19.29%28.96M |
Contract liabilities | -13.42%7.95M | 529.10%19.57M | 884.21%20.11M | -88.29%3.99M | 5.41%9.19M | 3,381.46%3.11M | 6,254.97%2.04M | 39,632.45%34.11M | 41,244.18%8.72M | -72.43%89.37K |
Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | --734.52K | ---- | ---- | ---- |
Salaries payable | 12.60%18.26M | 45.35%11.22M | 68.27%10.51M | 44.20%10.3M | 73.03%16.22M | 75.34%7.72M | 55.00%6.24M | 120.45%7.14M | 202.78%9.37M | 14.26%4.4M |
Taxs payable | -3.74%16.65M | -47.63%14.66M | -64.35%8.47M | -16.24%17.34M | -30.18%17.3M | 488.04%28M | 327.42%23.74M | 691.34%20.7M | 675.46%24.77M | 169.03%4.76M |
Other payable (including interest and dividends) | -39.75%11.44M | 38.50%10.74M | 95.65%10.64M | -48.08%9.65M | 0.44%18.99M | -83.58%7.76M | 49.68%5.44M | 501.81%18.58M | 385.35%18.91M | 2,314.18%47.22M |
-Other payable | -39.75%11.44M | ---- | 95.65%10.64M | ---- | 0.44%18.99M | ---- | 49.68%5.44M | ---- | 385.35%18.91M | ---- |
Non current liabilities due within one year | 73.50%113.05M | 240.30%103.31M | 188.54%93.94M | 166.84%64.85M | 167.87%65.16M | 66.58%30.36M | 4,260.08%32.56M | 3,192.54%24.3M | 2,862.94%24.32M | 1,307.27%18.22M |
Other current liabilities | -29.55%14.39M | -6.65%12.28M | 21.87%10.52M | 60.49%35.69M | 44.58%20.42M | -11.35%13.15M | -31.01%8.63M | 210.44%22.24M | 93.13%14.13M | --14.84M |
Total current liabilities | 23.07%520.61M | 51.63%513.63M | 87.74%469.96M | 68.06%468.55M | 119.53%423.03M | 92.53%338.74M | 135.84%250.32M | 230.68%278.8M | 194.15%192.7M | 170.23%175.94M |
Current liabilities | ||||||||||
Long term account payable | -51.02%35.28M | ---- | 8.49%34.83M | ---- | 45.60%72.03M | ---- | --32.1M | ---- | --49.47M | ---- |
Deferred tax liabilities | -12.05%26.44M | 18.55%27.72M | 64.59%28.54M | 74.55%29.23M | 152.46%30.07M | 101.68%23.38M | 1,260.39%17.34M | 1,188.76%16.75M | 816.42%11.91M | --11.59M |
Long term deferred income | 1.34%7.94M | 13.44%7.95M | 13.24%8.05M | 13.06%8.15M | 7.13%7.83M | -5.50%7M | -5.43%7.11M | -5.36%7.21M | -5.29%7.31M | -5.22%7.41M |
Lease liabilities | -26.35%3.71M | 358.18%5.12M | 166.98%4.4M | 243.81%5.22M | 261.49%5.03M | 102.80%1.12M | 3,484.39%1.65M | 485.64%1.52M | 228.51%1.39M | -28.07%550.62K |
Other non current liabilities | 0.19%85.65K | 0.05%85.49K | 0.10%85.49K | --85.49K | 0.23%85.49K | 0.46%85.45K | --85.41K | ---- | --85.3K | --85.06K |
Total non current liabilities | -41.57%105.03M | 24.72%152.05M | 46.44%139.14M | 65.02%185.18M | 109.03%179.75M | 99.22%121.91M | 975.55%95.02M | 1,123.06%112.21M | 810.83%85.99M | 612.76%61.19M |
Total liabilities | 3.79%625.63M | 44.51%665.67M | 76.38%609.1M | 67.19%653.73M | 116.29%602.78M | 94.26%460.65M | 200.36%345.34M | 318.26%391.01M | 271.83%278.69M | 221.79%237.13M |
Shareholders equity | ||||||||||
Paid-in capital | 0.70%93.57M | 0.08%92.99M | 0.08%92.99M | 0.12%92.92M | 0.12%92.92M | 0.80%92.92M | 0.80%92.92M | 0.68%92.81M | 0.68%92.81M | 0.00%92.18M |
Capital reserve funds | 12.55%327.35M | 4.24%303.13M | 8.96%297.56M | 16.54%290.81M | 19.61%290.84M | 21.52%290.81M | -8.05%273.08M | -11.44%249.54M | -9.53%243.17M | -9.44%239.31M |
Surplus reserve funds | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 0.00%15.31M | 32.78%15.31M |
Retained profit | -14.83%72.25M | -24.01%67.88M | -23.24%78.96M | -8.50%100.08M | -30.25%84.83M | -24.40%89.32M | -24.91%102.87M | -33.33%109.37M | -28.45%121.63M | -25.25%118.15M |
Other composite income | ---13.53K | ---5.98K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 5.08%508.47M | -1.85%479.3M | 0.13%484.82M | 6.87%499.11M | 2.32%483.9M | 5.03%488.36M | -10.58%484.18M | -15.60%467.03M | -13.43%472.91M | -11.61%464.95M |
Minority interests | 10.40%137.23M | 130.29%131.41M | 190.75%129.86M | 208.56%134.17M | 4,267.06%124.3M | 2,366.03%57.07M | 71.87%44.66M | 79.45%43.48M | -87.20%2.85M | -88.93%2.31M |
Total shareholder equity | 6.16%645.7M | 11.97%610.72M | 16.23%614.68M | 24.05%633.28M | 27.84%608.21M | 16.73%545.42M | -6.81%528.84M | -11.61%510.51M | -16.32%475.76M | -14.56%467.27M |
Total liabilityies and equity | 4.98%1.27B | 26.87%1.28B | 39.99%1.22B | 42.76%1.29B | 60.51%1.21B | 42.83%1.01B | 28.09%874.18M | 34.35%901.53M | 17.25%754.44M | 13.50%704.4M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | -- | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.